225 related articles for article (PubMed ID: 32096046)
1. Tau Prion-Like Propagation: State of the Art and Current Challenges.
Dujardin S; Hyman BT
Adv Exp Med Biol; 2019; 1184():305-325. PubMed ID: 32096046
[TBL] [Abstract][Full Text] [Related]
2. What is the evidence that tau pathology spreads through prion-like propagation?
Mudher A; Colin M; Dujardin S; Medina M; Dewachter I; Alavi Naini SM; Mandelkow EM; Mandelkow E; Buée L; Goedert M; Brion JP
Acta Neuropathol Commun; 2017 Dec; 5(1):99. PubMed ID: 29258615
[TBL] [Abstract][Full Text] [Related]
3. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
Clavaguera F; Tolnay M; Goedert M
Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
[TBL] [Abstract][Full Text] [Related]
4. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Annadurai N; De Sanctis JB; Hajdúch M; Das V
Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
[TBL] [Abstract][Full Text] [Related]
5. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments.
Kaniyappan S; Tepper K; Biernat J; Chandupatla RR; Hübschmann S; Irsen S; Bicher S; Klatt C; Mandelkow EM; Mandelkow E
Mol Neurodegener; 2020 Jul; 15(1):39. PubMed ID: 32677995
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
Hasegawa M
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
[TBL] [Abstract][Full Text] [Related]
7. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
[TBL] [Abstract][Full Text] [Related]
8. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
Holmes BB; Diamond MI
J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
[TBL] [Abstract][Full Text] [Related]
9. Invited review: Prion-like transmission and spreading of tau pathology.
Clavaguera F; Hench J; Goedert M; Tolnay M
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
[TBL] [Abstract][Full Text] [Related]
10. Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
Sala-Jarque J; Zimkowska K; Ávila J; Ferrer I; Del Río JA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232835
[TBL] [Abstract][Full Text] [Related]
11. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
12. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Lewis J; Dickson DW
Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.
Leroux E; Perbet R; Caillierez R; Richetin K; Lieger S; Espourteille J; Bouillet T; Bégard S; Danis C; Loyens A; Toni N; Déglon N; Deramecourt V; Schraen-Maschke S; Buée L; Colin M
Mol Ther; 2022 Feb; 30(2):782-797. PubMed ID: 34563677
[TBL] [Abstract][Full Text] [Related]
14. The structural line between prion and "prion-like": Insights from prion protein and tau.
Glynn C; Rodriguez JA; Hyman BT
Curr Opin Neurobiol; 2024 Jun; 86():102857. PubMed ID: 38489865
[TBL] [Abstract][Full Text] [Related]
15. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading.
Kundel F; Hong L; Falcon B; McEwan WA; Michaels TCT; Meisl G; Esteras N; Abramov AY; Knowles TJP; Goedert M; Klenerman D
ACS Chem Neurosci; 2018 Jun; 9(6):1276-1282. PubMed ID: 29590529
[TBL] [Abstract][Full Text] [Related]
16. Prion-like strain effects in tauopathies.
Han ZZ; Kang SG; Arce L; Westaway D
Cell Tissue Res; 2023 Apr; 392(1):179-199. PubMed ID: 35460367
[TBL] [Abstract][Full Text] [Related]
17. Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.
Alyenbaawi H; Allison WT; Mok SA
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33121065
[TBL] [Abstract][Full Text] [Related]
18. Trans-seeding of Alzheimer-related tau protein by a yeast prion.
Flach M; Leu C; Martinisi A; Skachokova Z; Frank S; Tolnay M; Stahlberg H; Winkler DT
Alzheimers Dement; 2022 Dec; 18(12):2481-2492. PubMed ID: 35142027
[TBL] [Abstract][Full Text] [Related]
19. Tau Secretion.
Ruan Z; Ikezu T
Adv Exp Med Biol; 2019; 1184():123-134. PubMed ID: 32096034
[TBL] [Abstract][Full Text] [Related]
20. Is tau ready for admission to the prion club?
Hall GF; Patuto BA
Prion; 2012 Jul; 6(3):223-33. PubMed ID: 22561167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
